End-to-end biomedical publication support with Embase indexing, Crossref DOI assignment, fast-track peer review in 3 to 7 days, and certified editorial assistance for researchers worldwide.
Six dedicated services that take your manuscript from draft to indexed publication.
Fast journal publication in Embase indexed biomedical and pharmacological journals with global discoverability through Emtree indexing.
Expedited editorial workflow delivering a high-quality peer review and decision within 3 to 7 days for urgent or time-sensitive submissions.
Permanent digital identifier for every paper through Crossref, ensuring lifelong traceability, citation tracking, and global discoverability.
Technical formatting to journal-specific guidelines plus professional proofreading and language editing for full scientific accuracy.
Receive an official, verifiable Certificate of Publication for every accepted manuscript, accepted by NMC, university promotion boards, and PhD evaluation panels.
Comprehensive pre-submission check including Similarity Index reports and technical formatting to ensure full compliance and reduce desk rejections.
Embase is the biomedical and pharmacological literature database from Elsevier. It is one of the most trusted research indexes in clinical medicine, drug research, and life sciences worldwide.
Start Your SubmissionRecords in the Embase database from over 95 countries.
Active peer-reviewed journals indexed in Embase.
Records exclusive to Embase and not found in MEDLINE.
New entries added to Embase every single day.
For biomedical researchers, clinicians, pharmacologists, and PhD scholars, getting indexed in Embase means your work is discoverable by global research teams, pharmaceutical companies, and systematic reviewers who depend on Embase for their evidence base.
Embase uses Emtree, a deep life-science thesaurus, which makes indexed papers more precisely searchable than papers indexed only in general databases. This precision is why Embase is the database of choice for clinical pharmacology, drug safety, and systematic review research.
Through IndexedPub, you get fast journal publication in Embase indexed journals without the long delays of traditional submission cycles, while keeping the credibility, peer review rigor, and Crossref DOI assignment that academic and promotion bodies expect.
Six clear steps from submission to Embase indexing. Most papers complete the journey in 2 to 3 weeks.
Upload your paper through our portal. Our team confirms receipt within 1 hour.
Plagiarism check via Turnitin or iThenticate, formatting review, and journal matching.
Domain experts review your paper. You receive an editorial decision within 72 hours.
Make any reviewer-recommended changes. Final acceptance is confirmed in writing.
Crossref DOI is registered. Your paper goes live with full metadata.
Your article is indexed in Embase with Emtree terms. We send you the verification link.
Our Embase indexed journal panel spans clinical, biomedical, and life-science specialties.
"Submitted on a Monday, accepted by Friday, indexed in Embase the next week. The fast-track process was exactly what my promotion timeline needed."
"The editorial team was responsive and professional. The Crossref DOI and Certificate of Publication arrived within days of acceptance."
"Genuine Embase indexing, transparent pricing, and clear communication throughout. I have referred three colleagues since."
Common questions about fast journal publication in Embase indexed journals.
Embase is a biomedical and pharmacological literature database from Elsevier with over 50 million records and 8,500 active indexed journals. Publishing in an Embase indexed journal increases the global visibility of your research, ensures discovery by clinicians and pharma researchers worldwide, and adds strong credibility to your academic profile.
Our fast-track workflow delivers an editorial decision within 72 hours and a complete peer review within 3 to 7 days. Final publication and DOI assignment typically happen within 7 to 14 days from submission, depending on revisions.
PubMed and MEDLINE are maintained by the US National Library of Medicine and use MeSH indexing. Embase is maintained by Elsevier, uses Emtree indexing, and includes around 17 million records that are not available in MEDLINE, with deeper coverage of European and pharmacological research.
Yes. Every paper accepted through IndexedPub receives a permanent Crossref DOI with optimized metadata, ensuring lifelong traceability, citation tracking, and discoverability.
We do not guarantee acceptance. Acceptance is decided by independent peer reviewers based on scientific merit. We do guarantee a fast, transparent process, expert editorial feedback, and placement support across our panel of Embase indexed journals.
Article processing charges vary by journal, subject area, and article type. Contact our team for a personalized quote based on your manuscript and target timeline.
You can download the official Embase journal list from the Elsevier website and verify any journal by ISSN. We recommend authors always confirm indexing status before submission, and we are happy to provide direct verification links for every journal on our panel.
Our panel covers cardiology, orthopaedics, internal medicine, obstetrics and gynaecology, pharmacology, dentistry, public health, nursing, oncology, neurology, biotechnology, and clinical research.
Yes. Every author receives a digital and print-ready Certificate of Publication with a unique verification ID for use in academic promotions, NMC submissions, PhD evaluations, and professional credentials.
Yes. Once indexed, your paper is searchable on Embase by title, author, DOI, and Emtree terms. We send a confirmation with the direct Embase record link as soon as indexing is complete.
Submit your manuscript today and get an editorial decision within 72 hours. Fast journal publication in Embase, backed by Crossref DOI and verifiable certification.